(Q62110057)

English

Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer

clinical trial

In more languages

default for all languages

No label defined

No description defined

Statements

0 references

A Phase I Study to Determine the Maximum Tolerated Dose of Daunoxome as Therapy for the Treatment of Metastatic Breast Cancer (English)

0 references

0 references

December 1997

0 references

research intervention

0 references

clinical trial phase

phase I clinical trial

0 references

research subject recruitment status

0 references

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q62110057&oldid=2149433062"